Jie Wang,
Xie, HaoFen
Hong Zhu,
Hu, Yue
Shanshan Mi,
Wang Ying,
Xu, QinHong
Yang, Liang
Article History
Received: 18 October 2024
Accepted: 24 January 2025
First Online: 4 March 2025
Declarations
:
: The study was performed in strict accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Hospital of Ningbo University 2024 Research No. 216RS. Access to participants’ personal medical records is restricted to researchers and monitoring personnel directly involved in the clinical trials. The trial records of the subjects are strictly safeguarded and have never been compromised. Participants provide informed consent prior to their involvement in the study. Throughout the trial, the rights of the subjects are fully respected, and they are provided with comprehensive information to help them understand the purpose, procedures, and potential risks and benefits of the trial. Participants have the right to withdraw from the study at any time.
: The study included individual data (including figures) for publication, and written informed consent was obtained from the patients.
: The authors declare no competing interests.